Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;51(2):507-518.
doi: 10.1007/s15010-022-01943-3. Epub 2022 Nov 3.

Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review

Affiliations
Review

Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review

Marco Busutti et al. Infection. 2023 Apr.

Abstract

Purpose: Visceral leishmaniasis (VL) has become a rising concern to transplantation teams, being associated with graft dysfunction and reduced survival of renal transplant recipients. Here, we describe a case of VL occurring in a kidney transplant (KT) recipient in Italy, a country in which Leishmania infantum is endemic and we reviewed the literature on the clinical course and diagnosis of VL in KT recipients residing or travelling to southern Europe.

Results: The VL case was diagnosed 18 months after transplant and 28 days after the onset of symptoms by quantitative PCR (qPCR) on peripheral blood. A graft biopsy showed renal involvement, and PCR performed on graft tissue displayed the presence of Leishmania DNA. The retrospective confirmation of Leishmania-positive serology in a serum sample collected before transplantation, as well as the absence of anti-Leishmania IgG in the graft donor strongly suggest that reactivation of a latent parasitic infection caused VL in the current case.

Conclusion: VL is often underdiagnosed in transplant recipients, despite the presence of latent Leishmania infection being reported in endemic countries. This case report, as well as the literature review on leishmaniasis in KT recipients, underline the importance of rapid VL diagnosis to promptly undergo treatment. Serology is scarcely sensitive in immunocompromised patients, thus molecular tests in peripheral blood should be implemented and standardized for both VL identification and follow-up.

Keywords: Infection; Kidney; Leishmania; Transplantation.

PubMed Disclaimer

Conflict of interest statement

All other authors declare that they have no relevant financial interests.

Figures

Fig. 1
Fig. 1
Molecular diagnosis and monitoring and histological evaluation of visceral leishmaniasis in a kidney transplant recipient. ac Time course of parasitological and laboratory parameters in the index patient. Parasitaemia was measured by quantitative real-time PCR (qPCR) before and after anti-leishmanial treatment (L-Amb). Detection of kDNA by qPCR was set up as described in Mary et al. [8]. The standard curve was created from Leishmania DNA extracted from 5 × 106 promastigotes of the L. infantum reference strain MHOM/TN/80/IPT1, performing serial dilution to 0.0005 parasites. Detection of kDNA reached the sensitivity of 0.05 parasite equivalents/ml. d. Histology examination of the kidney biopsy shows interstitial fibrosis and tubular atrophy (Trichrome stain, 10×). sCreat; serum creatinine levels. WBC; white blood cells. PLT platelets. Eq.par. equivalent parasites

References

    1. Gradoni L, López-Vélez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European Region. Geneva: World Health Organization; 2017.
    1. Clemente WT, Mourão PHO, Lopez-Medrano F, Schwartz BS, García-Donoso C, Torre-Cisneros J. Visceral and cutaneous leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S8–S15. doi: 10.1097/TP.0000000000002018. - DOI - PubMed
    1. Gajurel K, Dhakal R, Deresinski S. Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients. Clin Transpl. 2017;31:e12867. doi: 10.1111/ctr.12867. - DOI - PubMed
    1. La Hoz RM, Morris MI, Transplantation IDCOPOTASO Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients. Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:13546. - PubMed
    1. Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN. Renal involvement in leishmaniasis: a review of the literature. NDT Plus. 2011;4:147–152. - PMC - PubMed

MeSH terms